Cells made from human embryonic stem cells have been injected into the first patient in Geron's FDA-approved Phase I clinical trial. The trial hopes to show the safety of using cells taken from human embryos in patients with spinal cord injuries. The procedure took place on Friday in Atlanta.
Ed Rivet, Legislative Director for Right to Life of Michigan said, "We are concerned about the long-term safety of the patients in this trial. With the past experience of embryonic stem cells forming tumors, plus the potential immune rejection issues, we hope Geron and the FDA are not putting these patients at risk. Ultimately, this research is unethical and unjust. How is it that these embryos are human enough to scavenge their stem cells, but not human enough to be included in the human family?"